Ekso Bionics Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Note 8 - Goodwill and Intangible Assets (Tables)

Note 8 - Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		*June 30, 2025*
		*Gross Carrying Amount*				*Accumulated Amortization*				*Impairment*				*Net Carrying Amount*
Developed technology		$	2,310			$	(742	)		$	—			$	1,568
Trade name			2,310				N/A				—				2,310
Intellectual property			460				(18	)			(180	)			262
Customer relationships			140				(45	)			—				95
Total intangible assets		$	5,220			$	(805	)		$	(180	)		$	4,235

		*December 31, 2024*
		*Gross Carrying Amount*				*Accumulated Amortization*				*Impairment*				*Net Carrying Amount*
Developed technology		$	2,310			$	(598	)		$	—			$	1,712
Trade name			2,310				N/A				—				2,310
Intellectual property			460				(6	)			—				454
Customer relationships			140				(36	)			—				104
Total intangible assets		$	5,220			$	(640	)		$	—			$	4,580

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year		*Amount*
2025 - remainder		$	165
2026			330
2027			330
2028			330
2029			330
2030 and thereafter			440
Total		$	1,925